COMPANY
Origin
Origin is a clinical-stage biotechnology company with a patented high-energy plasma device that generates nitric oxide and delivers it to targeted locations in the body. From company website Source · Oct 12, 2026
Timeline
- Trial start Not phased (device or behavioral study): A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers source ↗
- Trial start Not phased (device or behavioral study): APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults source ↗
Clinical trials (lead sponsor) 2
| Record | Title | Phase | Status | Start | Primary completion |
|---|---|---|---|---|---|
| NCT03078933 | A Feasibility Study of Advance Plasma Therapy001 Plasma/Nitric Oxide Therapy for the Treatment of Diabetic Foot Ulcers | Not phased (device or behavioral study) | Unknown status (ClinicalTrials.gov) | Mar 20, 2017 | 2018-05 (estimated) |
| NCT02356835 | APT001 Plasma/NO Generator to Treat Diabetic Foot Ulcer in Adults | Not phased (device or behavioral study) | Completed | 2015-02 | 2016-01 (actual) |